Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6254 studies found for:    "Kidney Diseases"
Show Display Options
Rank Status Study
1 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
2 Recruiting Early-Stage Polycystic Kidney Disease Biomarkers Repository Study
Condition: Polycystic Kidney Disease
Intervention:
3 Completed Whole Body Vibration in Kidney Disease
Condition: Kidney Disease
Intervention: Procedure: Whole Body Vibration
4 Enrolling by invitation Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan (OPC-41061)
5 Withdrawn Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
6 Completed Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention: Dietary Supplement: Niacinamide
7 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
8 Completed Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
Condition: Kidney Disease
Intervention: Drug: Zemplar Capsule
9 Completed Pseudoexfoliation and Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention:
10 Unknown  Chronic Kidney Disease in Pakistani Population
Condition: Chronic Kidney Disease
Intervention:
11 Completed New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:
12 Completed
Has Results
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
Condition: Chronic Kidney Disease
Interventions: Drug: Placebo;   Drug: AST-120
13 Completed Efficacy, Safety, and Tolerability of GS-4997 in Participants With Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Interventions: Drug: GS-4997;   Drug: Placebo to match GS-4997
14 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
15 Active, not recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
16 Unknown  Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention: Drug: ketoaminoacid
17 Completed
Has Results
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)
Condition: Chronic Kidney Disease
Interventions: Drug: Placebo;   Drug: AST-120
18 Completed Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis
Condition: Kidney Disease
Intervention: Drug: Darbepoetin Alfa
19 Unknown  Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: Valsartan;   Drug: Perindopril
20 Unknown  A Research Proposal to Set up an Integrated National Data Bank and Monitoring System and to Establish the Indicators and Risk Factors for Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.